[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/main/docs/Technology/index.md) >> Individual ID:PBN__Technology_236 

# __Antiviral drugs__

## Category to which it belongs

* [Cutting-edge techniques, strategies, and technologies for pathogen detection, vaccine development, and global disease surveillance.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_195.md)

## Closest similar item

* [Advanced antiviral technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3293.md)
* [Anti-bacterial](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_827.md)
* [Anti-malaria drugs](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_836.md)
* [Antimalarial](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_790.md)
* [Antiretroviral therapy](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2281.md)
* [Antiviral](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3260.md)
* [Antiviral drug research](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3292.md)
* [Antivirals](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1918.md)
* [Antivirus software](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_237.md)
* [Medications](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3291.md)

## Risks linked to this technology

* [Lack of drug therapy options](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1139.md)

## This Technology enables the following mitigations

* [Drug therapies](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_3314.md)

## This technology is mentioned by

* [An environmental and health perspective for COVID-19 outbreak: Meteorology and air quality influence, sewage epidemiology indicator, hospitals disinfection, drug therapies and recommendations](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_270.md)

